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Background: Osteochondral interface regeneration is challenging for functional and
integrated cartilage repair. Various layered scaffolds have been used to reconstruct
the complex interface, yet the influence of the permeability of the layered structure
on cartilage defect healing remains largely unknown.
Methods: We designed and fabricated a novel bilayered scaffold using articular
cartilage extracellular matrix (ACECM) and hydroxyapatite (HAp), involving a porous,
oriented upper layer and a dense, mineralised lower layer. By optimising the
HAp/ACECM ratio, differing pore sizes and porosities were obtained simultaneously in
the two layers. To evaluate the effects of permeability on cell behaviour, rabbit
chondrocytes were seeded.
Results: Morphological observations demonstrated that a gradual interfacial region was
formed with pore sizes varying from 128.2 ± 20.3 to 21.2 ± 3.1 μm. The permeability of
the bilayered scaffold decreased with increasing compressive strain and HAp content.
Mechanical tests indicated that the interface was stable to bearing compressive and
shear loads. Accordingly, the optimum HAp/ACECM ratio (7 w/v%) in the layer to
mimic native calcified cartilage was found. Chondrocytes could not penetrate the
interface and resided only in the upper layer, where they showed high cellularity
and abundant matrix deposition.
Conclusions: Our findings suggest that a bilayered scaffold with low permeability,
rather than complete isolation, represents a promising candidate for osteochondral
interface tissue engineering.
Keywords: Extracellular matrix, Hydroxyapatite, Osteochondral interface, Bilayered
scaffold, PermeabilityIntroduction
Articular cartilage, a stable load-bearing unit, exhibits very poor regeneration capacity
if damaged due to its avascular nature and need for a precise physical environment.
Current clinical methods to repair defective cartilage include microfracture, mosaicplasty,
and autologous chondrocyte implantation, all of which are inadequate in their ability to
regenerate functional cartilage, both in terms of composition and mechanics [1,2]. In© 2014 Wang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication
waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise
stated.
Wang et al. BioMedical Engineering OnLine 2014, 13:80 Page 2 of 18
http://www.biomedical-engineering-online.com/content/13/1/80recent years, tissue engineering has become a promising strategy to repair cartilage and
osteochondral defects [3,4].
In fact, articular cartilage and the subchondral bone constitute a complex tissue
structure that involves a progressive gradient of material and physiological properties
[5]. The native osteochondral interface consists of a calcified cartilage layer [6] that is
flanked by an undulating tidemark and an even more irregular cement line adjacent to
the subchondral bone [7]. The mineral component in the calcified cartilage layer is similar
to, but distinct from, that found in bone [8]. Calcified cartilage becomes established at the
edges of a “permanent” epiphyseal bone layer (i.e., proximal reserve zone and articular
cartilage hypertrophic zone), and the tidemark serves as a barrier to vascular invasion and
the calcification of hyaline cartilage [9]. This structure is semi-permeable and permits the
passage of small molecules (<500 Da) from the subchondral bone to the articular cartilage
layer [10]. Moreover, this special barrier is essential for maintaining the integrity of
repaired cartilage over time and preventing osseous upgrowth into full-thickness defects
[11]. Thus, osteochondral interface regeneration needs more attention in repair cartilage
defects through tissue engineering techniques. A number of studies have developed
strategies to facilitate tissue integration at the osteochondral interface and have re-
established damaged articular cartilage [12-14].
In tissue engineering, scaffolds can provide an artificial and sometimes temporary
extracellular matrix (ECM), mimicking the structure and functionality of the native
ECM, to physically guide or chemically inform cell responses and thus promote tissue
growth [15]. Based on the native interface structure mentioned above, the ideal
cartilage-to-bone interface scaffold would support chondrocyte viability and promote
calcified cartilage matrix formation with appropriate physical properties. Thus, designing
and fabricating such a scaffold involving a gradient interfacial structure is a prerequisite
for the success of osteochondral tissue engineering.
In a previous study [16], we developed a novel articular cartilage ECM (ACECM)-derived
scaffold using decellularised human joint cartilage. This scaffold could support cell
attachment, proliferation, and mesenchymal stem cell differentiation and was used
in vivo for cartilage tissue engineering [16,17]. Because cartilage-specific ECM compo-
nents play an important role in chondrogenesis, as well as in supporting the chondrogenic
phenotype [18,19], other biomimetic scaffolds with oriented structures were fabricated
using temperature gradient-guided thermal-induced phase separation (TIPS) followed
by freeze-drying to mimic the biochemical composition and natural structure of native
articular cartilage [20,21]. Nevertheless, the gradient interface and permeability of the
calcified layer were not considered in the scaffold designing and manufacturing
process. Moreover, no study of interfacial low permeability in bilayered scaffolds for
osteochondral interface regeneration has yet been reported.
In this study, we designed and fabricated a novel bilayered scaffold using ACECM and
hydroxyapatite (HAp), which involved a porous oriented upper layer and a dense minera-
lised lower layer. The ingredient distribution and pore morphology were examined through
the interface. To achieve low permeability, the porosity and pore size were regulated by the
content ratio, and the permeability of the bilayered scaffold under different strain levels
was evaluated. To verify the feasibility of this integrative scaffold for osteochondral inter-
face tissue engineering, chondrocytes were then seeded on the bilayered scaffold for
in vitro evaluation. Cell viability and distribution on the scaffold were also characterised.
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Preparation of ACECM-HAp suspensions
Integrative, bilayered scaffolds were fabricated from a mineralised ACECM and nanophase
HAp (ACECM-HAp) suspension and a pure ACECM suspension. According to a method
developed in our laboratory [16,21], suspensions of porcine ACECM were prepared. The
cartilage slices were shattered and decellularised under aseptic conditions then smashed in
PBS buffer containing 3.5% (w/v) phenylmethyl sulphonylfluoride (Merck, Darmstadt,
Germany) and 0.1% (w/v) EDTA (Sigma, Poole, UK) for 60 min. The resulting suspension
of cartilage fragments was then centrifuged (500 × g). The decellularised ACECM microfi-
brils were washed extensively with sterile PBS and then made into a 3% (w/v) suspension
in PBS. The ACECM suspension was obtained and used without further processing. The
ACECM-HAp suspension was produced by combining (porcine) decellularised ACECM
microfibrillar and nanophase HAp, which was obtained commercially. Nano-sized HAp
particles (mean 20 nm; DK Nano Technology, Beijing, China) were mixed with 3% (w/v)
ACECM suspension at different weight to volume ratios and dispersed homogeneously in
a glass container. The effect of the ceramic dose was investigated by comparing scaffolds
with 3.5, 7, 10.5, or 14 w/v% HAp (i.e., 35, 70, 105, or 140 mg of HAp per mL of ACECM).
A magnetic blender was used for thorough mixing for 6 h at 37°C in the incubator; the
final mixture was then sonicated for 2 min. To remove any air introduced during the
mixing process, both suspensions were degassed under a vacuum (<300 mTorr) at
room temperature.
Fabrication of bilayered ACECM-HAp scaffolds
The two suspension types were loaded separately into two syringes. Both scaffold
components, a mineralised portion from the ACECM-HAp suspension and a non-
mineralised portion from the ACECM suspension, from separate liquid precursors were
used to fabricate a scaffold with a gradual coherent interface between the components
formed simultaneously using the “liquid-phase cosynthesis” technique [22]. The degassed
ACECM-HAp and ACECM suspensions were then injected sequentially into a custom
polypropylene cylindrical mould (inner diameter, 10 mm; height, 10 mm). To make the
contact intersurface more level, the layered suspensions were centrifuged at a low speed
(150 rpm/min) then allowed to interdiffuse at room temperature for 30 min before subse-
quent processing. The layered, interdiffused suspensions were then solidified using the
TIPS technique, followed by freeze-drying [21,23]. Briefly, a metal cylinder of the same
diameter was embedded in the upper end of the mould (non-mineralised side), and the
whole system was inverted then placed vertically onto a metal plate equilibrated to −196°C
and frozen in liquid nitrogen. This technique allowed for orientation of the structure of
the scaffold by solvent crystallisation under a unidirectional temperature gradient. The
frozen samples were lyophilised in a freeze-dryer (Boyikang, Beijing, China) for 48 h under
a vacuum.
After freeze-drying, the bilayered ACECM-HAp scaffolds were removed from the
mould and cross-linked (ultraviolet light, 258 nm, 4 h) prior to immersion in 95% (v/v)
alcohol containing 50 mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochlor-
ide (EDAC) and 20 mM N-hydroxysucinimide (Sigma) for 24 h at 4°C. Excess EDAC was
rinsed out of the scaffolds using PBS. The scaffolds were lyophilised then removed from
the mould and cut into the required size cylinders using a biopsy punch and scalpel.
Wang et al. BioMedical Engineering OnLine 2014, 13:80 Page 4 of 18
http://www.biomedical-engineering-online.com/content/13/1/80Scaffold cylinders (4 mm in diameter, ~3 mm thick) from independently prepared batches
were sterilised by 60Co γ-irradiation at 5 mRad. An additional movie file shows the
production process flow in more detail [see Additional file 1].
Structure characterisation and composition analysis
To determine the scaffold mean pore size, porosity, interconnectivity, and relative
distribution of minerals throughout the scaffold, ACECM-HAp scaffold samples (n = 3) were
analysed using micro computed tomography (microCT) with a 1-μm isotropic voxel reso-
lution under a 60-kV scanning voltage (1072 X-ray Microtomographer; SkyScan, Kontich,
Belgium). Visual inspection of each microCT frame captured (CTAn/CTVol Software
Package, v.1.13/v.2.2; SkyScan, Aartselaar, Belgium) through the thickness of the scaffold
allowed analysis of whether the HAp content remained distributed uniformly with the
ACECM content because of the differential opacity of ACECM versus HAp by microCT.
The ACECM-HAp scaffolds (n = 3) were analysed by scanning electron microscopy
(SEM) and energy-dispersive X-ray (EDX) spectroscopy to examine the local pore micro-
structure at the interface and to determine the mineral content and spatial distribution of
minerals within the scaffold. Full-thickness cylindrical samples were cut in half in vertical
sections, mounted on aluminium stubs, sputter-coated with gold, and observed by SEM
(Hitachi BCPCAS-4800, Tokyo, Japan) at an accelerating voltage of 15 kV. Line scan and
compositional map data were acquired via EDX spectroscopy for the calcium (Ca) and
phosphorous (P) contents as well as other elements.
Fourier transform infrared (FTIR) spectroscopy
The presence of nanoparticles and the resulting chemical composition of the ACECM-HAp
scaffolds (n = 5) were analysed by FTIR spectroscopy (Spectrum One; Perkin Elmer,
Waltham, MA, USA) in transmission mode. Transparent potassium bromide pellets
were prepared, followed by uniaxially pressing the powders under a vacuum. All
spectra were obtained between 4400 and 450 cm−1 at a 2-cm−1 resolution. A dry system
was used to prevent atmospheric moisture.
Unconfined and confined compressive testing
The bilayered scaffolds (n = 6) were placed into a confined compression chamber and
attached to a standard materials testing machine with a 225-N load cell (ElectroForce
3220; BOSE, Eden Prairie, MN, USA). A preload of 0.05 N was applied to ensure contact
between the scaffold surface and the porous indenter. To ensure that the tissues were fully
hydrated, the samples were kept immersed in PBS until testing. Mechanical tests were
performed at a constant compression rate of 0.05 mm/s to a maximum strain of 35%. The
same-sized single-layer (ACECM and ACECM-HAp) scaffolds were put into the confined
compression chamber and tested with the test sequence described previously. For
unconfined compression testing, bilayered or single-layer scaffolds (n = 6) were positioned
between two permeable steel platens. The same testing regime as that described for con-
fined testing was used.
Interface shear strength test
The interfacial shear properties of the bilayer scaffolds (n = 6) were assessed using a
custom shear holding device held in the testing machine. Scaffolds were kept hydrated
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and adjusted so that a metal shearing plate contacted the tissue ~0.5 mm from the
bilayered scaffold interface. The tests involved a 0.02 mm/s crosshead velocity. The
peak load at failure was taken as the highest point corresponding to the first observed
peak on the load–displacement curve, and the shear stiffness was calculated using the
slope of the steepest and most linear portion of the curve up to this peak load.
Permeability analysis
The specimens tested for permeability included all ACECM scaffolds and ACECM-HAp
scaffolds as well as the bilayered ACECM-HAp scaffolds (n = 5, each). Permeability
was determined by a falling-head conductivity test based on Darcy’s law [24]. A custom
chamber device was constructed to provide different levels of compressive strain on
the scaffolds and to measure the variation in fluid height. The device consisted mainly
of 1) a standpipe to provide a falling head, 2) a permeability chamber to host the scaffold
and adjust the levels of applied compressive strain (with a scale in mm), and 3) a reservoir
for fluid collection (Figure 1A).
Two stainless steel meshes were adhered to the openings of the standpipe and cham-
ber to ensure uniform compressive strain on the scaffold. The mesh did not inhibit or
disrupt fluid flow through the tube. The standpipe, with a 7.5-mm inner diameter,
could be screwed into the permeability chamber, for a volume 8.0 mm in diameter, for
the host sample. The level of compressive strain was regulated by adjusting the depth
of the standpipe screw. Cylindrical samples (8.4 mm in diameter, 7.0 mm thick) were
cut from the various scaffolds using a corneal punch. Saline solution (0.9% NaCl) was
used as the fluid medium for the permeability test. Before measurement, the samples
were submerged in saline solution for 1 h under negative pressure to remove air bubbles
trapped in the structure.
As shown in Figure 1A, the initial height (H1) of fluid in the standpipe was recorded at
time 1 (t1). While liquid permeated through the scaffold, the time (t2) required for the
fluid head to drop from the upper to the lower level (H2) was recorded using a stopwatch.
The permeability (k) and hydraulic conductivity (K) of the scaffold under each level of
applied compressive strain were calculated on the basis of Darcy’s law [24]:












where μ is the dynamic viscosity, ρ is the fluid medium density, a is the cross-sectional
area of the standpipe, A is the cross-sectional area of the sample, and L is the sample
thickness under compression. To obtain reproducible results, the permeability was
measured five times for each sample.
Isolation of chondrocytes and cell seeding on the scaffolds
Rabbit chondrocytes were obtained from New Zealand White rabbits as described
previously [25]. The protocol was approved by the Institutional Animal Care and
Figure 1 Permeability determination. A: Experimental set-up for the measurement of permeability. B:
Permeability changes in different types of scaffolds (7 w/v% HAp) under compressive strain. C: Experimentally
measured permeability of bilayered scaffolds with various HAp contents and applied compressive strain. The
data are means ± SDs, * p < 0.05, versus respective bilayered scaffolds at the same strain.
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cultured and expanded in regular culture medium (DMEM supplemented with 10%
foetal bovine serum, 300 mg/mL L-glutamine, 50 mg/mL vitamin C, 100 U/mL penicillin,
and 100 U/mL streptomycin) and passaged three times (P3) before use.
The bilayer scaffolds (4 mm in diameter, 3 mm thick; n = 18) were sterilised with
ethylene oxide and placed into a 6-well culture plate rinsed with medium for 20 min,
and 35-μL cell suspensions of ~1 × 105 cells were seeded onto each sample until the
scaffold became completely saturated. The cell-scaffold constructs were then incubated
for 4 h at 37°C at 95% humidity/5% CO2 to allow for complete adhesion of the cells to
the scaffolds. Next, the constructs were covered with pre-warmed regular culture
medium and cultured under the same conditions. The medium was replaced every 2–3
days and the constructs were harvested for further evaluation.Cell behaviour: observation of the bilayered scaffold
Cell attachment was confirmed by direct visualisation of the constructs using SEM (n = 3)
after 7 days in culture. The cell-scaffold constructs were fixed in 2.5% glutaraldehyde,
dehydrated through a graded ethanol series to 100% ethanol, treated with hexamethyldisi-
lazane, and sputter-coated with gold/palladium before viewing. Histological examination
of the cell-scaffold constructs was also performed using haematoxylin and eosin (H&E),
safranin O, toluidine blue, and alizarin red staining.
Cell viability in the scaffolds was evaluated at 3, 7, and 14 days (n = 3 each) using a
Live/Dead assay kit (fluorescein diacetate [FDA]-propidium iodide [PI]; Sigma). Live
cells were stained with FDA and dead cells were labelled with a working solution of PI for
5 min. The stained constructs were viewed under an Olympus IX81 confocal microscope
(Tokyo, Japan).Statistical analyses
All data are presented as means ± SDs. A one-way analysis of variance and post hoc
Student-Newman-Keuls test were used to assess differences in the porosity data, biomech-
anical data, and permeability data. P-values < 0.05 were considered to indicate statistical
significance.Results
Structural characterisation of the bilayered scaffolds
The manufactured scaffolds matched the original design. Macroscopic (Figure 2A) and
electron microscopic observations (Figure 2B) of the bilayered prototype revealed a
remarkable area of continuity at the interface. Thus, the two layers showed good
combining characteristics, a requirement necessary to ensure excellent integrity and
functionality of the interfacial construct. The pore structures of the upper and lower
layers were distinct. The pores within the upper layer were microtubule-like and
arranged in parallel in longitudinal sections (Figure 2B–D), each with a characteristic
three-dimensional (3D) interconnected pore structure. The nanofibrous ACECM
aligned along the longitudinal orientation in the vertical section image at a high mag-
nification (Figure 2E). Distinct from the upper layer, the lower layer was denser, with
an arbitrary composition; nanophase HAp particles were uniformly distributed throughout
Figure 2 Structural characterisation of the bilayered scaffolds. A: Gross appearance of the scaffold
prototype. B–F: Analysis of longitudinal sections of the bilayered scaffold by SEM showing the upper layer
(B), interface region (C and D), and nanofibrous ECM orientation in the upper layer of the scaffold wall at a
high magnification (E) and in the lower layer (F).
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at the interface (Figure 2F).
The scaffold structure and porosity were also assessed by microCT. Images of the
bilayered scaffold microstructure are shown in Figure 3A (side profile and three transverse
cross-sections through the scaffold disk taken from the upper, interfacial, and lower
regions). The translucent upper layer (non-mineralised) was clearly distinguishable
from the HAp-free component and the more opaque lower layer (mineralised) was the
HAp-containing component. An analysis of serial cross-sections (n = 6 per scaffold com-
ponent) of the microCT images (Figure 3B) allowed calculation of the mean pore size in
the upper and lower layers. The pores in both the mineralised and non-mineralised com-
ponents were multidimensional, with mean pore sizes of 128.2 ± 20.3 and 21.2 ± 3.1 μm,
Figure 3 Architecture characterisation. A: Analysis of cross-sectional images of the bilayered scaffold by
microCT showing the upper layer (a), interface region (b), and lower layer (c) of the scaffold (position marked
by a dashed line). B: Pore size distribution at distinct thicknesses. C: Porosity of the upper and lower layers with
various HAp contents. The data are means ± SDs. *p < 0.05.
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different pore structures can be obtained using the current methods. The material
porosity of the bilayered scaffold was calculated using SkyScan CTAn Software with
microCT and indicated a porosity of 92.6 ± 6% in the non-mineralised components
and from 44 ± 3 to 30 ± 4% (with 3.5, 7, 10.5, or 14 w/v% HAp) in the mineralised
components (Figure 3C). Also, the upper layer showed larger porosity than the lower
layers (p = 0.001). Likewise, imaging of the interfacial region of the bilayered scaffold by
microCT showed, as did SEM (Figure 2C and D), a lack of crevices or discontinuities at
the interface (Figure 3A).Compositional analysis and FTIR spectroscopy
Distinct mineralised (high calcium [Ca] and P contents) and non-mineralised (low to
non-existent Ca and P contents) regions were revealed within the scaffold via EDX analysis
of the bilayered scaffold (from the top, through the thickness), corresponding to the known
locations of the ACECM-HAp and ACECM scaffold components (Figure 4A). A uniform
distribution was observed within the lower layer, whereas little or no mineral content was
observed in the upper layer. Quantification of the mineral (Ca or P) content through the
thickness of the bilayered scaffold showed a high concentration of minerals in the lower
layer that was almost two orders of magnitude greater than the mineral content in the
upper layer, which was negligible (Figure 4A, right side). Furthermore, the distribution of
carbon and oxygen (Figure 4A, left side) indicated no angular interface between the two
layers.
FTIR spectroscopy can be an effective approach to define the existence of each compo-
nent within a complex system containing different types of materials. Figure 4B shows the
FTIR spectra of the non-cross-linked nanophase HAp crystal particles and cross-linked
Figure 4 Compositional analysis. A: EDX analysis of the bilayered scaffold; solid and dashed arrows
highlight the mineralised (upper layer) and unmineralised (lower layer) compartments, respectively. B: FTIR
measurements of the cross-linked ACECM scaffold, ACECM-HAp (with 7 w/v% HAp) bilayered scaffold, and
non-cross-linked nanophase HAp crystal particles.
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Typical infrared bands showed characteristic phosphate (PO4
3-) absorption bands at
566.16, 602.87, and 1039.08 cm-1, indicating HAp nanoparticles, which were not ob-
served in the ACECM-only spectrum. The characteristic absorption bands of ACECM
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Nevertheless, the FTIR spectra of cross-linked ACECM-HAp showed no new ad-
sorption band in any range; the peaks were shifted slightly with respect to the
standard values for PO4
3- adsorption bands, which may be due to the interaction
between the ceramic and the collagen phase [24]. This finding is probably the re-
sult of the material preparation and cross-linking methods not affecting their
chemical environment.
Mechanical properties
Typical stress–strain curves for three different forms of the scaffolds obtained from
both confined and unconfined compression tests are shown in Figure 5A and B. The
compressive modulus was determined from the slope of the linear elastic stage in the
curve. The single-layer (ACECM) scaffolds had a relatively low compressive modulus
(Figure 5C), whereas the single-layer (ACECM-HAp) scaffolds had a significantly higher
compressive modulus compared with the other groups under confined and unconfined
situations. The modulus of the bilayered scaffolds ranged between the values of the two
single-layer scaffolds. Thus, the addition of HAp to the ACECM construct increased the
compressive modulus, and the scaffold structure significantly affected the mechanical
capacity.
A representative shear load–displacement curve of the bilayered scaffold is shown
in Figure 5D; corresponding values for shear stiffness and peak load at fracture onFigure 5 Mechanical properties. A: Unconfined compression of the single-layer and bilayered scaffolds. B:
Confined compression of the single-layer and bilayered scaffolds. C: Compressive moduli in confined and
unconfined compression (20% strain) of various scaffolds. The data are means ± SDs. *p < 0.05. D: Typical
shear load–displacement curve of the interfacial zone of a bilayered scaffold.
Table 1 Interfacial shear properties of bilayered scaffold with various HAp content in
hydrated status
HAp35 mg/mL HAp70 mg/mL HAp105 mg/mL HAp140 mg/mL
Peak load (N) 1.33 ± 0.21 0.86 ± 0.06 0.54 ± 0.10 0.28 ± 0.04
Shear stiffness (N/mm) 1.28 ± 0.13 0.79 ± 0.09 0.41 ± 0.05 0.22 ± 0.08
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was calculated by determining the maximum slope of the most linear portion of the
load–displacement curve for each sample. The interfacial shear resistance of the bilayered
scaffold decreased with increasing HAp content in the lower layer. The shear stiffness was
higher in the scaffolds containing a low HAp content than in the scaffolds containing a
high HAp content (p < 0.001).Permeability
The permeability (Figure 1A) of the single-layer (ACECM) scaffold ranged from
62.1 × 10−13 to 48.7 × 10−13 m2 with increasing compressive strain from 0 to 30%, but
in the bilayered scaffold, regardless of the concentration of HAp, the permeability was
significantly smaller compared with the single-layer (ACECM) scaffold (Figure 1B). The
permeability of the bilayered scaffold with 0.07 mg/mL HAp decreased from 2.2 × 10−13
to 1.4 × 10−13 m2 with increasing compressive strain, and that of the single-layer
(ACECM-HAp) scaffold decreased from 1.6 × 10−13 to 0.2 × 10−13 m2 with increasing
compression (Figure 1B). In contrast, the permeabilities of the bilayered scaffold and
the single-layer (ACECM-HAp) scaffold without strain were similar, with no significant
difference between the two scaffolds in the rate of decline under strain. With the bilayered
scaffold, the permeability was affected by the HAp content (Figure 1C). Generally, the
value decreased with an increasing HAp content under various compressions.Cell morphology on the scaffold
After in vitro culture, a zonal, shiny cartilage-like tissue at the macroscopic level was
generated when rabbit chondrocytes were seeded onto ACECM-HAp scaffolds for 7 days.
The scaffold seeded with chondrocytes was cartilage-like tissue in gross view (Figure 6A).
Histological staining showed all upper layers of the constructs were intensely stained
with safranin O and toluidine blue, indicating an ECM rich in sulphated proteoglycans
(Figure 6B and C), while the lower layers of the constructs (Figure 6E and F) indicated
overexpression due to the presence of mineralised Ca and P, as in the unseeded scaffolds
(Figure 6H and I). Positive alizarin red staining of the lower layers indicated the rich
Ca content in both the cell-scaffold constructs (Figure 6D) and the unseeded scaffolds
(Figure 6G), suggesting the mineralization of the materials, while the upper layers of
the constructs were negative for staining due to the absence of Ca and P. SEM and
H&E staining (Figure 7) showed that the chondrocytes were well-distributed in the
non-mineralised component (Figure 7A–C) of the bilayered scaffolds, with a few cells
adhering to the interfacial zone (Figure 7D–F), although no cells entered into the
mineralised component (Figure 7G–I), indicating a cell-barrier layer. Figure 8 shows
the cell viability of rabbit chondrocytes seeded on the bilayered scaffolds with FDA
and PI staining after culture for 3, 7, and 14 days. On day 3, the upper layer exhibited
Figure 6 Chondrocytes seeded on bilayered scaffolds after 7 days of culture. A: Gross observation.
B and C: Upper layer. D–F: Interfacial zone and lower layer. G–I: Interfacial zone and lower layer of unseeded
scaffold as control. D and G: Alizarin red staining. B, E, and H: Toluidine blue staining. C, F, and I: Safranin O staining.
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incubation time, more live cells could be observed aligned along the microtubules on
day 7 (Figure 8B and E). Up to 2 weeks, more cells showed a fusiform morphology,
were in good condition, and were aligned along vertical microtubules and adapted to
upper layers of the scaffold (Figure 8C and F). However, dead cells were evident too; a
few adhered to the scaffolds. The cell distribution was consistent with our findings by
SEM, especially the finding that few cells infiltrated the lower layer.
Discussion
Interfacial tissue engineering is a promising strategy for osteochondral defect regener-
ation, but it is challenging to fabricate a suitable tissue engineered scaffold because of the
complex interfacial structure and varying composition. In this study, we used ACECM
combined with HAp to fabricate a novel bilayered scaffold involving a porous oriented
upper layer and a dense mineralised lower layer. In fact, the performance of the pore
architecture can significantly affect cellular responses and in vivo bioactivity [22]. This
bilayered scaffold showed a uniform pore microstructure and high interconnectivity. The
pores in the upper layer were microtubule-like and arranged in parallel in vertical sections
(Figure 2A–C). Notably, the pore size between the two layers decreased gradually, and the
pore morphology changed to a round shape, indicating an apparent transition region,
similar to a natural calcified cartilage layer [9].
We reported previously that ACECM scaffolds exhibited good biocompatibility for
supporting cell attachment and proliferation in in vitro and in vivo studies [16,20].
Figure 7 Cell distribution of tissue engineered constructs after 7 days in culture. A–C: Upper layer.
D–F: Interfacial zone. G–I: Lower layer. A, B, D, E, G, and H: Images produced by SEM. C, F, and I:
H&E staining.
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http://www.biomedical-engineering-online.com/content/13/1/80Additionally, recent findings indicated that the proportion of HAp as an inorganic
compound in the calcified cartilage layer was ranked only second to that of subchondral
bone [8]. In the present bilayered scaffold, the mineralised layer consisted of a mixture of
ACECM and HAp while the non-mineralised layer consisted of ACECM alone. Using
low-speed centrifugation in the preparation process can distribute the HAp in the
ACECM with a gradient concentration, as confirmed by our EDX spectroscopic results
(Figure 4).
Viewed from the natural cartilage structure, the calcified layer plays an important role
in the transmission of substance and signals, leading to different niches on both sides, for
chondrocyte and osteoblast growth. Some studies have shown that bone marrow-derived
mesenchymal stem cells (MSCs), which are recruited from the marrow cavity to a
cartilage defect site during the healing process, resulted in poor long-term effects
[26,27]. Lories et al. [28] also demonstrated that the calcified layer served as a vital
physical barrier between the cartilage and subchondral bone, providing the articular
cartilage with an independent environment. We conclude that low permeability, rather
than complete isolation, at the interface is beneficial for cartilage reconstruction. Cell
migration from both sides should be prevented, but nutritional and other factors can
be straight for wardly transported between the layers. Accordingly, this bilayered
structure was designed to provide ideal niches for different functional layer formation.
The mean pore size of the lower layer in this structure was controlled within 20 μm
(Figure 3B), which could prevent cell movement. Transport within the scaffold was
assessed by measurement of the permeability, and the results corresponded largely
with our expectations. The permeability of the bilayered scaffold differed significantly
Figure 8 Live/dead staining of bilayered scaffolds seeded with chondrocytes. A and D: Cells cultured
for 3 days. B and E: Cells cultured for 7 days. C and F: Cells cultured for 14 days. D–F: High magnification
view of a rectangular area in A–C. Green: live cell staining; Red: dead cell staining.
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http://www.biomedical-engineering-online.com/content/13/1/80from that of the single-layer (ACECM) scaffold. However, the differences in construct
permeability suggested significantly higher levels of metabolite diffusion in the upper
layer, allowing increased cell proliferation and facilitating cell migration to the interface.
An in vitro study indicated that greater scaffold permeability enhanced chondrogenic
differentiation of bone marrow MSCs, whereas less permeable scaffolds were favourable
for chondrocyte growth [29].
Permeability is an effective parameter in evaluating tissue engineering scaffolds that
could reflect important parameters such as the combination of porosity, pore size and
distribution, interconnectivity, fenestration size and distribution, and pore orientation
[30]. Several experimental methods have been developed to test scaffold permeability
according Darcy’s law and/or the Forchheimer equation [31]. The falling head conduct-
ivity test is a gravity-based direct method. Lee et al. [32] evaluated the permeability of
3D porous poly (propylene fumarate) scaffolds with a controlled pore size architecture
using the falling head method. Additionally, Al-Munajjed et al. [33] analysed how pore
size influenced the permeability of hyaluronic-collagen scaffolds. Mansour and Mow
[34] found that the permeability of cartilage ranged from 0.1 to 2 × 10−15 m2 while cartil-
age permeability depended on the composition, tissue depth, and mechanical conditions.
Cartilage permeability decreased with increasing tissue depth, as far as the calcified layer.
For cartilage regeneration, the effect of compressive strain on scaffold permeability is an
important feature to determine because many tissue engineering constructs are used in
loading-bearing applications that can significantly influence construct permeability, as
well as metabolite diffusion, but few studies have used this method to evaluate permeabil-
ity. The scaffold permeability data under compressive strain in this work show that the
permeability decreased with increasing strain, similar to the relationship between perme-
ability and compression found by Lai and Mow for articular cartilage [35]. O’Brien et al.
[36] found that collagen scaffold permeability increased with increasing pore size and de-
creased with increasing compressive strain, which was also supported by a mathematical
analysis.
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http://www.biomedical-engineering-online.com/content/13/1/80The native calcified cartilage region forms an interface with the underlying subchondral
bone, and this transitional region may generate substantial shear stress because of
the large discrepancy in tissue stiffness [37]. As the mechanical test results showed,
determination of the compressive modulus of the bilayered scaffold demonstrated
that the presence of this mineralised zone improved the compressive performance
versus a scaffold without a mineralised zone. This finding was attributed to the more
submissive non-mineralised layer undergoing large deformations under compressive
loading, which resulted in almost total densification of the upper zone at stresses insuffi-
cient to cause observable deformation in the lower zone. Additionally, the shear strength
of the interface was determined and the results were competent compared with other
reports [38,39]. In all specimens, the low HAp content groups (35 and 70 mg/mL)
performed better than the high HAp content groups (105 and 140 mg/mL), in which
a fracture occurred in the lower layer. With regard to permeability, 70 mg/mL HAp
was the most suitable candidate for calcified cartilage formation. Additionally, this
bilayered structure could provide good initial stability and mechanical support during im-
plantation. Our aim in the present study was to develop a novel scaffold that would have
distinct yet continuous matrix regions. Successful realisation of this goal would be a sig-
nificant advance towards developing interface tissue engineering solutions for soft-hard
tissue integration and biological fixation.
The promising utility of bilayered scaffold for tissue engineering depends on the
capacity to direct cells to express a desired phenotype in specific niches. Additionally, a
prerequisite for biomimetic scaffold design is a clear understanding of the structure-
function relationship at the cartilage-to-bone interface. The cell affinity of the scaffold
is important for tissue regeneration and functional reconstruction [40]. We found
that cell proliferation was maintained throughout the culture period. SEM revealed
that the chondrocytes aligned vertically along the microtubules in the upper layer,
but that few cells adhered to the interfacial zones, and no cells entered into the
lower layer (Figure 7). Due to restrictions in the structure of the scaffold, cells cannot
penetrate the mineralised layer, and cultured chondrocytes may not affect the deposition
of Ca and P. Based on previous studies [41-43], as an osteoconductive material, HAp
ceramics have the ability to provide an appropriate scaffold or template for bone
formation; it has been used extensively as a substitute in bone grafts because the
crystalline phase of natural bone is basically HAp. From the point of view of these
applications in combination with our results, we hypothesise that the mineralised region
of the bilayered scaffold may promote bone formation via an in situ tissue regeneration
process [44,45]. For tissue engineering applications, a controlled scaffold orientation
is needed because the alignment of the scaffold guides cellular growth and spatial
alignment [46]. In this study, the cell distribution was biomimetic to the native
physiological structure of deep zone cartilage and the calcified zone.Conclusions
In summary, we designed and fabricated an ACECM-HAp bilayered scaffold containing a
porous, oriented upper layer and a dense, mineralised lower layer. A gradual interfacial
region was formed by optimising the HAp/ACECM ratio. Different porosities and pore
sizes of the two layers resulted in low permeability, rather than complete isolation,
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http://www.biomedical-engineering-online.com/content/13/1/80which could promote the formation of a local microenvironment and avoid delamin-
ation. The mechanical properties and observed cell affinity demonstrate that this
bilayered scaffold could represent a promising candidate for cartilage interface tissue
engineering applications. To better understand the function of this bilayered scaffold
for interface reconstruction, a comparative evaluation of the different cell activities in
both layers is needed. Future studies should focus on using representative animal
models to explore the feasibility of in vivo applications. The key factors of the culture
conditions (i.e., dynamic bioreactor cultivation) are also worthy of investigation.
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